Designed specifically for dense breast tissue. By combining cutting-edge AI with 3D volumetric ultrasound technology, we are elevating early detection rates to world-leading levels and redefining healthcare standards for women globally.
For the majority of women globally with dense breast tissue, traditional screening methods face significant limitations. Hundreds of millions of women need a more precise solution.
In dense breasts, lesions often overlap with healthy tissue, leading to a missed diagnosis rate as high as 40% - 60%.
Blind-spot-free tomographic scanning with AI-assisted lesion localization completely solves the tissue overlap issue.
Radiation-free, highly comfortable, and automatically acquires complete 3D breast data, breaking the dependency on an operator's manual skills.
Deep learning algorithms analyze massive 3D data in real-time, accurately identifying tiny calcifications and masses to assist doctors.
Secure data aggregation in the cloud empowers grassroots clinics, enabling efficient, standardized screening operations at a massive scale.
Direct connection to top-tier hospital expert teams, breaking geographical barriers to provide authoritative remote reviews.
In Shenzhen, a city of 20 million, PathoVision's comprehensive solution has been fully implemented. Validated by large-scale screening, we have increased the early breast cancer detection rate by nearly 8 times, reaching and exceeding international leading levels.
* Source: Shenzhen Health Commission & Field Validation. Results published in the American Journal of Roentgenology and the St. Gallen Breast Cancer Conference.